Cargando…
The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma
Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expression...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253406/ https://www.ncbi.nlm.nih.gov/pubmed/32400857 http://dx.doi.org/10.1042/BSR20190239 |
_version_ | 1783539331145662464 |
---|---|
author | Liu, Jin Zhu, Mingyi Feng, Yun Tang, Qianli Xu, Meng |
author_facet | Liu, Jin Zhu, Mingyi Feng, Yun Tang, Qianli Xu, Meng |
author_sort | Liu, Jin |
collection | PubMed |
description | Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expressions of LRP and P-gp were detected by Western blot and real-time PCR. Result: The RIs of CNE/DDP group to DDP, 5-Fu, VCR, ADR and PTX were 35.04, 18.14, 24.13, 12.00 and 10.18, respectively. The RIs of LY-294002 group were 11.77, 5.83, 3.07, 3.86 and 3.34, and PDTC group were 11.08, 6.55, 7.66, 2.18 and 4.05. The expressions of PI3K, p-Akt and NF-κBp65, LRP and P-gp were increased and mRNA of LRP and P-gp were up-regulated in CNE/DDP. The expression of p-Akt in LY-294002 group was down-regulated. The expression of NF-κB p65 in PDTC group was decreased. The mRNA of LRP and P-gp in LY-294002 group and PDTC group were decreased. Conclusion: MDR of nasopharyngeal carcinoma cell can be regulated by activating PI3K/Akt/NF-κB signal pathway and then increase the expression of P-gp and LRP. The MDR of nasopharyngeal carcinoma cell can be reversed by inhibiting PI3K/Akt/NF-κB signal pathway. |
format | Online Article Text |
id | pubmed-7253406 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Portland Press Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-72534062020-06-08 The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma Liu, Jin Zhu, Mingyi Feng, Yun Tang, Qianli Xu, Meng Biosci Rep Cancer Aim: To investigate the relationship between PI3K/Akt/NF-κB cellular signal pathway and the expression of P-gp and LRP in multidrug resistance (MDR) cell of nasopharyngeal carcinoma. Method: The PI3K, p-Akt and NF-κB/p65 as the activity of PI3K/Akt/NF-κB were detected by Western blot. The expressions of LRP and P-gp were detected by Western blot and real-time PCR. Result: The RIs of CNE/DDP group to DDP, 5-Fu, VCR, ADR and PTX were 35.04, 18.14, 24.13, 12.00 and 10.18, respectively. The RIs of LY-294002 group were 11.77, 5.83, 3.07, 3.86 and 3.34, and PDTC group were 11.08, 6.55, 7.66, 2.18 and 4.05. The expressions of PI3K, p-Akt and NF-κBp65, LRP and P-gp were increased and mRNA of LRP and P-gp were up-regulated in CNE/DDP. The expression of p-Akt in LY-294002 group was down-regulated. The expression of NF-κB p65 in PDTC group was decreased. The mRNA of LRP and P-gp in LY-294002 group and PDTC group were decreased. Conclusion: MDR of nasopharyngeal carcinoma cell can be regulated by activating PI3K/Akt/NF-κB signal pathway and then increase the expression of P-gp and LRP. The MDR of nasopharyngeal carcinoma cell can be reversed by inhibiting PI3K/Akt/NF-κB signal pathway. Portland Press Ltd. 2020-05-27 /pmc/articles/PMC7253406/ /pubmed/32400857 http://dx.doi.org/10.1042/BSR20190239 Text en © 2020 The Author(s). https://creativecommons.org/licenses/by/4.0/ This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY). |
spellingShingle | Cancer Liu, Jin Zhu, Mingyi Feng, Yun Tang, Qianli Xu, Meng The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title | The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title_full | The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title_fullStr | The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title_full_unstemmed | The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title_short | The multidrug resistance can be reversed for the decrease of P-gp and LRP by inhibiting PI3K/Akt/NF-κB signal pathway in nasopharynx carcinoma |
title_sort | multidrug resistance can be reversed for the decrease of p-gp and lrp by inhibiting pi3k/akt/nf-κb signal pathway in nasopharynx carcinoma |
topic | Cancer |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253406/ https://www.ncbi.nlm.nih.gov/pubmed/32400857 http://dx.doi.org/10.1042/BSR20190239 |
work_keys_str_mv | AT liujin themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT zhumingyi themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT fengyun themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT tangqianli themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT xumeng themultidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT liujin multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT zhumingyi multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT fengyun multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT tangqianli multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma AT xumeng multidrugresistancecanbereversedforthedecreaseofpgpandlrpbyinhibitingpi3kaktnfkbsignalpathwayinnasopharynxcarcinoma |